Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy is a research paper published in PLoS Computational Biology (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA254271
National Cancer Institute
Grant: R01NS115971
National Cancer Institute
Grant: P30CA033572
California Institute of Regenerative Medicine
Grant: CLIN2-10248
National Institutes of Health
Grant: 5R01DK000562-34
METABOLIC MECHANISMS
National Institutes of Health
Grant: 5R01CA254271-02
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
National Institutes of Health
Grant: 5R01NS115971-04
The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
Marcus Foundation
FWCI
2.05
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude
Additional file 1 of CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude
Additional file 2 of CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude
Additional file 2 of CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude